Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lantheus Medical Imaging

Clinical trials sponsored by Lantheus Medical Imaging, explained in plain language.

Lantheus Medical Imaging LNTH NASDAQ

A company developing diagnostic imaging agents.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2

New radiation drug targets bone cancer cells directly

Disease control Recruiting now

This study tests a new drug called LNTH-2403, which delivers radiation directly to cancer cells in people with osteosarcoma (a type of bone cancer) that has returned or not responded to standard treatments. The drug is given as an injection and aims to shrink tumors or slow their…

Phase: PHASE1, PHASE2 • Sponsor: Lantheus Medical Imaging • Aim: Disease control

Last updated Jun 27, 2026 12:28 UTC